Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Oct;234(10):633-6.
doi: 10.1007/BF00185297.

Interleukin 10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis

S Hayashi  1 , Y Guex-Crosier, A Delvaux, T Velu, F G Roberge
Affiliations
Comparative Study

Interleukin 10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis

S Hayashi et al. Graefes Arch Clin Exp Ophthalmol. 1996 Oct.

Abstract

Background: Endotoxin-induced uveitis (EIU) is a model for acute anterior uveitis associated with a variety of pro-inflammatory cytokines and nitric oxide production. Interleukin 10 (IL-10) down-regulates these inflammatory mediators. We report a study of the effect of systemic administration of IL-10 on the inflammatory parameters of EIU.

Methods: Uveitis was induced in C3H/HeN mice by subcutaneous injection of 200 micrograms lipopolysaccharide (LPS) per mouse. Intraocular inflammation was assessed by leukocyte count and measurement of the protein concentration in the aqueous humor (AH). Mouse recombinant IL-10 at 1000 U or its vehicle alone were administered by three intravenous injections given 4.0 h and 0.5 h before and 8.0 h after LPS injection.

Results: The inflammatory cell infiltration in the eyes was significantly reduced in four of five experiments from 40% to 64% in the groups treated with IL-10 compared to the control groups (P < 0.05). In contrast, the level of protein exudation in the anterior chamber (AC) was not significantly affected by IL-10 treatment.

Conclusion: IL-10 reduces the cellular infiltration in the ocular inflammation produced by endotoxin. This result suggests potential usefulness for IL-10 in the treatment of severe anterior uveitis with a strong cellular component.

PubMed Disclaimer

References

    1. Eur J Immunol. 1994 May;24(5):1167-71 - PubMed
    1. Transplantation. 1994 Oct 27;58(8):972-4 - PubMed
    1. J Exp Med. 1993 Feb 1;177(2):547-50 - PubMed
    1. J Exp Med. 1991 Dec 1;174(6):1549-55 - PubMed
    1. J Exp Med. 1989 Dec 1;170(6):2081-95 - PubMed

Publication types